Skip to main content

GENERAL ATLANTIC, L.P.

Position in CNTA — Centessa Pharmaceuticals plc

CIK 1017645 New York, NY

Position in CNTA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,354,830
-77.9% QoQ
Ownership
0.876%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GENERAL ATLANTIC, L.P. holds $541,727,121 across 5 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CNTA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 1,354,830
2025-12-31 6,117,715
2025-09-30 9,681,818
2025-06-30 9,681,818
2025-03-31 9,681,818
2024-12-31 9,681,818
2024-09-30 9,681,818
2024-06-30 9,681,818
2024-03-31 9,681,818
2023-12-31 9,681,818
2023-09-30 9,681,818
2023-06-30 9,681,818
2023-03-31 9,681,818
2022-12-31 9,681,818
2022-09-30 9,681,818
2022-06-30 9,681,818
2022-03-31 9,681,818
2021-12-31 9,681,818
2021-09-30 9,681,818
2021-06-30 1,500,000